← Browse by Condition
Medical Condition

asthma with eosinophilic phenotype

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06653322 Phase 3
Recruiting

A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma

Enrollment
400 pts
Location
China
Sponsor
Guangdong Hengrui Pharmaceutic...
View Trial →